The best medical device stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
The top health product stocks included on this page all trade on the S&P 500, have an analyst recommendation of "Buy" or better and are sorted by year-to-date performance.
Top pick for banking + investing in one app
Top pick for copy trading
Get 12 free shares
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Abbott Laboratories stock opened the day at $106.15 after a previous close of $109.40. The latest price was $106.20 (25-minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD48.2 billion and employs 122,000 staff.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.
ABIOMED stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). ABIOMED is listed on the NASDAQ, has a trailing 12-month revenue of around USD$1.1 billion and employs 2,003 staff.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.
Align Technology stock opened the day at $156.27 after a previous close of $151.58. The latest price was $164.90 (25-minute delay). Align Technology is listed on the NASDAQ, has a trailing 12-month revenue of around USD$4.1 billion and employs 20,435 staff.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve.
Edwards Lifesciences stock opened the day at $98.58 after a previous close of $95.19. The latest price was $99.37 (25-minute delay). Edwards Lifesciences is listed on the NYSE, has a trailing 12-month revenue of around USD$6.5 billion and employs 16,000 staff.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems.
Boston Scientific stock opened the day at $42.95 after a previous close of $43.50. The latest price was $41.98 (25-minute delay). Boston Scientific is listed on the NYSE, has a trailing 12-month revenue of around USD$21 billion and employs 59,000 staff.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Medtronic stock opened the day at $100.20 after a previous close of $98.88. The latest price was $104.96 (25-minute delay). Medtronic is listed on the NYSE, has a trailing 12-month revenue of around USD$37.5 billion and employs 95,000 staff.
Penumbra, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Penumbra stock opened the day at $320.56 after a previous close of $320.02. The latest price was $318.95 (25-minute delay). Penumbra is listed on the NYSE, has a trailing 12-month revenue of around USD$1.6 billion and employs 4,700 staff.
Inogen, Inc. , a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Inogen stock opened the day at $7.13 after a previous close of $6.86. The latest price was $7.22 (25-minute delay). Inogen is listed on the NASDAQ, has a trailing 12-month revenue of around USD$354.3 million and employs 753 staff.
SmileDirectClub, Inc. , an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria.
SmileDirectClub stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). SmileDirectClub is listed on the NASDAQ, has a trailing 12-month revenue of around USD$414.9 million and employs 2,700 staff.
Check out Finder's picks for the best brokerage accounts
Compare top brokerage accounts and apps to help you maximize your investment.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Connect an AI agent like Claude or ChatGPT to a ring-fenced Robinhood account, or build one in the app, and let it trade for you. Here’s how it works, what it can trade and the risks before you switch
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash and more. Compare your options here.
Check out our picks of the best ETF brokers for beginners, options trading, micro-investing and more.
Interactive Brokers is the best overall international brokerage account on our list, followed by Moomoo, Fidelity, Charles Schwab and TradeStation.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
These are the best discount brokers of 2026 according to Finder’s comprehensive review.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .